1. Kirkwood JM, Ibrahim J, Sondak V, et al. Role of high-dose IFN in high-risk melanoma: preliminary results of the E1690/S9111/C9190 US intergroup postoperative adjuvant trial of high and low-dose IFNα2b (HDI and LDI) in resected high-risk primary or regionally lymph node metastatic melanoma in relation to 10-year updated results of E1684. 23rd Annual Congress of the European Society for Medical Oncology (ESMO). Athens, November, 1998.
2. Role of interferons and other cytokines in the regulation of the immune response;Belardelli;APMIS,1995
3. Implications for immunosurveillance of altered class I phenotypes in human tumours;Garrido;Immunol Today,1997
4. Heterogeneity of HLA-G transcription and protein expression in malignant melanoma biopsies;Paul;Cancer Res,1999
5. HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance;Paul;Proc Natl Acad Sci USA,1998